Paul R. Afolabi

Southampton, ENG SO166YD, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma.

Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma.

Journal: Cancers

Published: March 01, 2025

Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma.

Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma.

Journal: Cancers

Published: October 29, 2023

Markers of adipose tissue fibrogenesis associate with clinically significant liver fibrosis and are unchanged by synbiotic treatment in patients with NAFLD.

Markers of adipose tissue fibrogenesis associate with clinically significant liver fibrosis and are unchanged by synbiotic treatment in patients with NAFLD.

Journal: Metabolism: clinical and experimental

Published: September 27, 2023

Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the "obesity paradox" phenomenon.

Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the "obesity paradox" phenomenon.

Journal: Clinical nutrition ESPEN

Published: July 20, 2022

DEPEND study protocol: early detection of patients with pancreatic cancer - a pilot study to evaluate the utility of faecal elastase-1 and 13C-mixed triglyceride breath test as screening tools in high-risk individuals.

DEPEND study protocol: early detection of patients with pancreatic cancer - a pilot study to evaluate the utility of faecal elastase-1 and 13C-mixed triglyceride breath test as screening tools in high-risk individuals.

Journal: BMJ open

Published: February 26, 2022

Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD.

Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD.

Journal: Nutrition & diabetes

Published: February 15, 2021

European guideline on indications, performance and clinical impact of 13 C-breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC.

European guideline on indications, performance and clinical impact of 13 C-breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC.

Journal: United European gastroenterology journal

Published: February 08, 2021

Factors independently associated with cardiorespiratory fitness in patients with non-alcoholic fatty liver disease.

Factors independently associated with cardiorespiratory fitness in patients with non-alcoholic fatty liver disease.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 21, 2020

Non-alcoholic fatty liver disease and childhood obesity.

Non-alcoholic fatty liver disease and childhood obesity.

Journal: Archives of disease in childhood

Published: March 20, 2020

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.

Journal: Gastroenterology

Published: April 01, 2019

The evaluation of the repeatability of the 13C-ketoisocaproate breath test for assessing hepatic mitochondrial function.

The evaluation of the repeatability of the 13C-ketoisocaproate breath test for assessing hepatic mitochondrial function.

Journal: Isotopes in environmental and health studies

Published: March 19, 2019

The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the 13C-ketoisocaproate breath test.

The characterisation of hepatic mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD) using the 13C-ketoisocaproate breath test.

Journal: Journal of breath research

Published: June 27, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026